JCR Pharmaceuticals Co., Ltd. (OTCMKTS:JCRRF) Short Interest Update

JCR Pharmaceuticals Co., Ltd. (OTCMKTS:JCRRF) was the recipient of a significant growth in short interest in the month of November. As of November 30th, there was short interest totalling 477,000 shares, a growth of 16.7% from the November 15th total of 408,600 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is currently ∞ days.

JCR Pharmaceuticals Stock Performance

Shares of OTCMKTS JCRRF opened at $4.57 on Friday. The company has a 50 day simple moving average of $4.57 and a 200-day simple moving average of $4.70. JCR Pharmaceuticals has a 1 year low of $4.30 and a 1 year high of $4.70.

JCR Pharmaceuticals Company Profile

JCR Pharmaceuticals Co, Ltd., together with its subsidiaries, engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan. It offers various therapeutic products, including GROWJECT used for the treatment of growth hormone deficiency and short stature; IZCARGO to treat Mucopolysaccharidosis type II; Agalsidase Beta BS I.V.